Parasitol Res. 2012 Jul;111(1):195-203. doi: 10.1007/s00436-012-2818-9.
Cryptolepine (5-methyl-10H-indolo [3, 2-b] quinoline), an indoloquinoline alkaloid (1) isolated from a medicinal plant traditionally used in Western Africa for treatment of malaria, has been shown to possess broad spectrum biological activity in addition to its antiplasmodial effect. Here, the antileishmanial properties of 11 synthetic derivatives of cryptolepine against Leishmania donovani parasites have been evaluated for the first time. 2,7-Dibromocryptolepine (8; IC50 0.5 ± 0.1 μM) was found to be the most active analogue against the promastigote form of a classical L. donovani strain (AG83) in comparison to the natural alkaloid, cryptolepine (1; IC50 1.6 ± 0.1 μM). Further, 8 was found to substantially inhibit the intracellular amastigote forms of two clinical isolates, one of them being an SbV-resistant strain of L. donovani. Moreover, the toxicity of 8 against normal mouse peritoneal macrophage cells was markedly lower than that of 1 (IC50 values: 9.0 ± 1.2 and 1.1 ± 0.3 μM, respectively), indicating 8 to be a prospective “lead” towards novel antileishmanial therapy. This was supported by studies on the mechanism of cytotoxicity induced by 8 in L. donovani promastigotes (AG83), which revealed the cytoplasmic and nuclear features of metazoan apoptosis. Light microscopic observation demonstrated a gradual decline in the motility, cell volume, and survival of the treated parasites with increasing incubation time. Flow cytometric analysis of phosphatidylserine externalization and distribution of cells in different phases of cell cycle confirmed the presence of a substantial percentage of cells in early apoptotic stage. Disruption of mitochondrial membrane integrity in terms of depolarization of membrane potential, and finally degradation of chromosomal DNA into oligonucleosomal fragments - the hallmark event of apoptosis - characterized the mode of cell death in L. donovani promastigotes.
隐丹参酮(5-甲基-10H-吲哚并[3,2-b]喹啉),一种从药用植物中分离出来的吲哚喹啉生物碱(1),在非洲西部传统上用于治疗疟疾,除了抗疟原虫作用外,还具有广谱的生物活性。在这里,首次评估了 11 种隐丹参酮的合成衍生物对利什曼原虫寄生虫的抗利什曼原虫特性。与天然生物碱隐丹参酮(1;IC50 1.6 ± 0.1 μM)相比,2,7-二溴隐丹参酮(8;IC50 0.5 ± 0.1 μM)被发现对经典利什曼原虫株(AG83)的前鞭毛体形式最具活性。此外,8 还发现可显著抑制两种临床分离株的细胞内无鞭毛体形式,其中一种是利什曼原虫的 SbV 耐药株。此外,8 对正常小鼠腹腔巨噬细胞的毒性明显低于 1(IC50 值分别为 9.0 ± 1.2 和 1.1 ± 0.3 μM),表明 8 是一种潜在的新型抗利什曼病治疗的“先导化合物”。这一发现得到了 8 在利什曼原虫前鞭毛体(AG83)中诱导细胞毒性的机制研究的支持,该研究揭示了真核动物细胞凋亡的细胞质和核特征。光镜观察显示,随着孵育时间的增加,处理寄生虫的运动性、细胞体积和存活率逐渐下降。流式细胞术分析表明,细胞内磷脂酰丝氨酸外排和细胞周期不同阶段细胞分布证实了早期凋亡阶段存在大量细胞。线粒体膜完整性的破坏,以膜电位去极化的形式,以及最终染色体 DNA降解为寡核苷酸片段——凋亡的标志性事件——是利什曼原虫前鞭毛体细胞死亡的模式。